

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.78591924 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.63649907 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.63649907 |
| 4 | positive thymic T cell selection (GO:0045059) | 4.21533348 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00842928 |
| 6 | positive T cell selection (GO:0043368) | 3.97349376 |
| 7 | negative T cell selection (GO:0043383) | 3.91000897 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.88822584 |
| 9 | negative thymic T cell selection (GO:0045060) | 3.87381579 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81939174 |
| 11 | thymic T cell selection (GO:0045061) | 3.76113493 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71980136 |
| 13 | leukocyte aggregation (GO:0070486) | 3.68098051 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61229215 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60437719 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60437719 |
| 17 | regulation of integrin activation (GO:0033623) | 3.60358709 |
| 18 | T cell selection (GO:0045058) | 3.59991705 |
| 19 | positive regulation of Rap GTPase activity (GO:0032854) | 3.57538471 |
| 20 | response to type I interferon (GO:0034340) | 3.56648823 |
| 21 | type I interferon signaling pathway (GO:0060337) | 3.53798038 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.53798038 |
| 23 | detection of bacterium (GO:0016045) | 3.50963182 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.45795596 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45529003 |
| 26 | embryonic process involved in female pregnancy (GO:0060136) | 3.44341495 |
| 27 | detection of other organism (GO:0098543) | 3.42491282 |
| 28 | signal complex assembly (GO:0007172) | 3.41663578 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33920348 |
| 30 | protein localization to endosome (GO:0036010) | 3.32225876 |
| 31 | regulation of ARF protein signal transduction (GO:0032012) | 3.27803595 |
| 32 | tolerance induction (GO:0002507) | 3.24737917 |
| 33 | regulation of Rap GTPase activity (GO:0032317) | 3.23648527 |
| 34 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.22219781 |
| 35 | cellular response to zinc ion (GO:0071294) | 3.17030963 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16028596 |
| 37 | response to interleukin-15 (GO:0070672) | 3.12017153 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11702112 |
| 39 | positive regulation of protein homooligomerization (GO:0032464) | 3.08956628 |
| 40 | regulation of ARF GTPase activity (GO:0032312) | 3.08076970 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.04517428 |
| 42 | response to laminar fluid shear stress (GO:0034616) | 3.01595735 |
| 43 | locomotory exploration behavior (GO:0035641) | 3.00747736 |
| 44 | mannose metabolic process (GO:0006013) | 3.00277408 |
| 45 | proline biosynthetic process (GO:0006561) | 2.98969646 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.98719366 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.95839916 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 2.94328805 |
| 49 | B cell homeostasis (GO:0001782) | 2.92279988 |
| 50 | regulation of necroptotic process (GO:0060544) | 2.90880081 |
| 51 | negative regulation of protein oligomerization (GO:0032460) | 2.90720335 |
| 52 | response to muramyl dipeptide (GO:0032495) | 2.90096084 |
| 53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88949543 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 2.88182494 |
| 55 | T cell migration (GO:0072678) | 2.82294833 |
| 56 | regulation of histone H3-K27 methylation (GO:0061085) | 2.80709733 |
| 57 | negative regulation of type 2 immune response (GO:0002829) | 2.78779975 |
| 58 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77554854 |
| 59 | embryonic placenta development (GO:0001892) | 2.76571214 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 2.76260576 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.76005485 |
| 62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75274963 |
| 63 | negative regulation of innate immune response (GO:0045824) | 2.75228483 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74641731 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 2.71473041 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70726378 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.68760453 |
| 68 | cellular response to interleukin-15 (GO:0071350) | 2.68583045 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 2.68095634 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 2.67927780 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67399230 |
| 72 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.66800417 |
| 73 | T cell homeostasis (GO:0043029) | 2.65852321 |
| 74 | cellular extravasation (GO:0045123) | 2.63929985 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.63056496 |
| 76 | oxygen transport (GO:0015671) | 2.62288109 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.61212364 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61071319 |
| 79 | synaptic vesicle maturation (GO:0016188) | 2.60755219 |
| 80 | lymphocyte homeostasis (GO:0002260) | 2.59351061 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 2.59052577 |
| 82 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.58871482 |
| 83 | regulation of defense response to virus by virus (GO:0050690) | 2.57367232 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 2.56574327 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56514890 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54919420 |
| 87 | negative regulation of stress fiber assembly (GO:0051497) | 2.54796903 |
| 88 | response to peptidoglycan (GO:0032494) | 2.54219294 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.54033281 |
| 90 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.53906143 |
| 91 | positive regulation of histone deacetylation (GO:0031065) | 2.53134487 |
| 92 | negative regulation of necroptotic process (GO:0060546) | 2.52492218 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52445327 |
| 94 | modulation by symbiont of host cellular process (GO:0044068) | 2.52047437 |
| 95 | regulation of protein homooligomerization (GO:0032462) | 2.51562905 |
| 96 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.51515988 |
| 97 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.51281294 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50324337 |
| 99 | response to host (GO:0075136) | 2.50324337 |
| 100 | response to host defenses (GO:0052200) | 2.50324337 |
| 101 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50042803 |
| 102 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50042803 |
| 103 | activation of Rac GTPase activity (GO:0032863) | 2.50024695 |
| 104 | interferon-gamma secretion (GO:0072643) | 2.49521387 |
| 105 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49484301 |
| 106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46693428 |
| 107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46693428 |
| 108 | modulation by symbiont of host immune response (GO:0052553) | 2.46693428 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46693428 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 2.46693428 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46693428 |
| 112 | modulation by virus of host process (GO:0019054) | 2.45643358 |
| 113 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.45531129 |
| 114 | T cell costimulation (GO:0031295) | 2.45415093 |
| 115 | natural killer cell differentiation (GO:0001779) | 2.45241571 |
| 116 | negative regulation of Ras GTPase activity (GO:0034261) | 2.45000110 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.44426336 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 2.43584240 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.42137414 |
| 120 | activation of JUN kinase activity (GO:0007257) | 2.41013680 |
| 121 | stress fiber assembly (GO:0043149) | 2.40943517 |
| 122 | lymphocyte costimulation (GO:0031294) | 2.39967323 |
| 123 | activated T cell proliferation (GO:0050798) | 2.37426572 |
| 124 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.37100640 |
| 125 | peptidyl-threonine phosphorylation (GO:0018107) | 2.36907584 |
| 126 | T cell receptor signaling pathway (GO:0050852) | 2.36868071 |
| 127 | regulation of regulatory T cell differentiation (GO:0045589) | 2.36712656 |
| 128 | monocyte differentiation (GO:0030224) | 2.33137507 |
| 129 | neuromuscular process controlling balance (GO:0050885) | 2.32750362 |
| 130 | neuromuscular process controlling posture (GO:0050884) | 2.32511900 |
| 131 | positive regulation of B cell differentiation (GO:0045579) | 2.31806300 |
| 132 | negative regulation of viral release from host cell (GO:1902187) | 2.31346603 |
| 133 | mature B cell differentiation (GO:0002335) | 2.30638909 |
| 134 | sodium ion export (GO:0071436) | 2.30211424 |
| 135 | regulation of macrophage chemotaxis (GO:0010758) | 2.29749242 |
| 136 | mast cell degranulation (GO:0043303) | 2.29052560 |
| 137 | mast cell activation involved in immune response (GO:0002279) | 2.29052560 |
| 138 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.28866628 |
| 139 | adaptation of signaling pathway (GO:0023058) | 2.27791248 |
| 140 | replication fork processing (GO:0031297) | 2.25057789 |
| 141 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.23458778 |
| 142 | interferon-gamma production (GO:0032609) | 2.23074222 |
| 143 | adenosine receptor signaling pathway (GO:0001973) | 2.22848016 |
| 144 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.22708988 |
| 145 | positive regulation of Rac GTPase activity (GO:0032855) | 2.22698666 |
| 146 | histone H3-K36 demethylation (GO:0070544) | 2.22037851 |
| 147 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.20992590 |
| 148 | peptidyl-threonine modification (GO:0018210) | 2.20250416 |
| 149 | synaptic vesicle exocytosis (GO:0016079) | 2.19894782 |
| 150 | germinal center formation (GO:0002467) | 2.18629396 |
| 151 | leukocyte cell-cell adhesion (GO:0007159) | 2.18618751 |
| 152 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.18033645 |
| 153 | pre-miRNA processing (GO:0031054) | 2.16392787 |
| 154 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.16302607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28878521 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.52077009 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.17682194 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.98634128 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.71712684 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.71503741 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66811596 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.49455058 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.45900019 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44330090 |
| 11 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.42736317 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.31929641 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19099803 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18855917 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18664508 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11994156 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10680305 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.02879629 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97392225 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94098236 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91663949 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89568220 |
| 23 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.89384435 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89084619 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88578702 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85845584 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83235691 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80847838 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80254941 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78271218 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75528322 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74574897 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74552339 |
| 34 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.69459340 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65868071 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.65377500 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61232481 |
| 38 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60612104 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.58819085 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58544676 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55417443 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54980052 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.52340657 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48044042 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44806903 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43543689 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42993686 |
| 48 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.42404387 |
| 49 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40501419 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36640041 |
| 51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33734690 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31390736 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30892552 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29775149 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29428554 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.29071452 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28574220 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25370239 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25181932 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23998735 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21949403 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21898005 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21202354 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21066300 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20917765 |
| 66 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20181138 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19760077 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.18499860 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15474518 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15210289 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14165801 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13953582 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13850210 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12950050 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11667447 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10525004 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10204113 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09092118 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08706935 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08420105 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07824165 |
| 82 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07435155 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06605728 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05623744 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05225950 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03932780 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03928604 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03635257 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02985421 |
| 90 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01993364 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01970251 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01624892 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01531026 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01500335 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98613861 |
| 96 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98180251 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98172158 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97823148 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97637618 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97630143 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97461533 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96407046 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96064391 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95092293 |
| 105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94673202 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94655476 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94224030 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93948495 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93489786 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93227605 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92423609 |
| 112 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.92059731 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91418258 |
| 114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91377100 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91302672 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91091155 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90733472 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87806717 |
| 119 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87169001 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86057650 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85416853 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85006404 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84898965 |
| 124 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84771023 |
| 125 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.84383982 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84265333 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83539305 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83346876 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81083218 |
| 130 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80189095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.40901585 |
| 2 | MP0009278_abnormal_bone_marrow | 3.15048936 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.71104698 |
| 4 | MP0000685_abnormal_immune_system | 2.62030598 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.59540839 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.59362864 |
| 7 | MP0005387_immune_system_phenotype | 2.51278934 |
| 8 | MP0001790_abnormal_immune_system | 2.51278934 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.47823787 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.44784176 |
| 11 | MP0003303_peritoneal_inflammation | 2.41187502 |
| 12 | MP0001800_abnormal_humoral_immune | 2.37844418 |
| 13 | MP0003045_fibrosis | 2.37691567 |
| 14 | MP0003724_increased_susceptibility_to | 2.37058687 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.29279319 |
| 16 | MP0005671_abnormal_response_to | 2.27404546 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.25325131 |
| 18 | MP0002822_catalepsy | 2.24632061 |
| 19 | MP0004510_myositis | 2.18099946 |
| 20 | MP0005451_abnormal_body_composition | 2.13113083 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.98005588 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.98005588 |
| 23 | MP0005174_abnormal_tail_pigmentation | 1.97997179 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.95809269 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.92114883 |
| 26 | MP0006082_CNS_inflammation | 1.88077271 |
| 27 | MP0004381_abnormal_hair_follicle | 1.87911328 |
| 28 | MP0005310_abnormal_salivary_gland | 1.87633303 |
| 29 | MP0002398_abnormal_bone_marrow | 1.87561242 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.85806528 |
| 31 | MP0002723_abnormal_immune_serum | 1.85276655 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.78672529 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.77904352 |
| 34 | MP0001819_abnormal_immune_cell | 1.75848266 |
| 35 | MP0001873_stomach_inflammation | 1.73756354 |
| 36 | MP0002006_tumorigenesis | 1.71229410 |
| 37 | MP0003866_abnormal_defecation | 1.68920691 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.68828402 |
| 39 | MP0002405_respiratory_system_inflammati | 1.67565069 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.66055968 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.64135432 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.62888586 |
| 43 | MP0001851_eye_inflammation | 1.61627368 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.61598845 |
| 45 | MP0008057_abnormal_DNA_replication | 1.61496885 |
| 46 | MP0008260_abnormal_autophagy | 1.61106637 |
| 47 | MP0003075_altered_response_to | 1.60921967 |
| 48 | MP0000716_abnormal_immune_system | 1.60039383 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.59765994 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.54213975 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.47085468 |
| 52 | MP0003787_abnormal_imprinting | 1.46251467 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.44746657 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.42268573 |
| 55 | MP0002722_abnormal_immune_system | 1.41775236 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.40838802 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.39388726 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.39191112 |
| 59 | MP0002009_preneoplasia | 1.38462654 |
| 60 | MP0000858_altered_metastatic_potential | 1.37423523 |
| 61 | MP0003436_decreased_susceptibility_to | 1.35527064 |
| 62 | MP0008995_early_reproductive_senescence | 1.33191885 |
| 63 | MP0002064_seizures | 1.31581706 |
| 64 | MP0008874_decreased_physiological_sensi | 1.31088628 |
| 65 | MP0005025_abnormal_response_to | 1.29721958 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.27729287 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.25794084 |
| 68 | MP0002419_abnormal_innate_immunity | 1.25118443 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.23754681 |
| 70 | MP0009046_muscle_twitch | 1.22742550 |
| 71 | MP0001849_ear_inflammation | 1.22383740 |
| 72 | MP0009745_abnormal_behavioral_response | 1.20992016 |
| 73 | MP0002429_abnormal_blood_cell | 1.19559462 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 1.17561638 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.17521677 |
| 76 | MP0008569_lethality_at_weaning | 1.17046689 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.16693797 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.14226331 |
| 79 | MP0004947_skin_inflammation | 1.13782520 |
| 80 | MP0008877_abnormal_DNA_methylation | 1.13070045 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.12208025 |
| 82 | MP0001853_heart_inflammation | 1.09598600 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 1.05147297 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.03159571 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.01934850 |
| 86 | MP0003633_abnormal_nervous_system | 1.01837368 |
| 87 | MP0000371_diluted_coat_color | 0.99280949 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.99236548 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.99233930 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.97067678 |
| 91 | MP0002132_abnormal_respiratory_system | 0.97060825 |
| 92 | MP0002933_joint_inflammation | 0.96973193 |
| 93 | MP0002928_abnormal_bile_duct | 0.93540515 |
| 94 | MP0003091_abnormal_cell_migration | 0.93437318 |
| 95 | MP0008469_abnormal_protein_level | 0.93252956 |
| 96 | MP0005409_darkened_coat_color | 0.89812274 |
| 97 | MP0002796_impaired_skin_barrier | 0.88834701 |
| 98 | MP0005621_abnormal_cell_physiology | 0.87547121 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.84634964 |
| 100 | MP0010307_abnormal_tumor_latency | 0.83204596 |
| 101 | MP0009840_abnormal_foam_cell | 0.83146660 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.82198158 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.80436587 |
| 104 | MP0004130_abnormal_muscle_cell | 0.79793037 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.79588601 |
| 106 | MP0005171_absent_coat_pigmentation | 0.79453069 |
| 107 | MP0003283_abnormal_digestive_organ | 0.79329140 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.78295322 |
| 109 | MP0005023_abnormal_wound_healing | 0.76763019 |
| 110 | MP0004233_abnormal_muscle_weight | 0.75334716 |
| 111 | MP0005670_abnormal_white_adipose | 0.75325225 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.74127531 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.73429921 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.73425617 |
| 115 | MP0000604_amyloidosis | 0.73120829 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.71839436 |
| 117 | MP0001970_abnormal_pain_threshold | 0.71028161 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.70965703 |
| 119 | MP0005166_decreased_susceptibility_to | 0.69705292 |
| 120 | MP0003690_abnormal_glial_cell | 0.69090870 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.68967904 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.68834793 |
| 123 | MP0000490_abnormal_crypts_of | 0.68742784 |
| 124 | MP0003448_altered_tumor_morphology | 0.67166112 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.66943179 |
| 126 | MP0009785_altered_susceptibility_to | 0.66326352 |
| 127 | MP0003329_amyloid_beta_deposits | 0.65975939 |
| 128 | MP0001486_abnormal_startle_reflex | 0.65852030 |
| 129 | MP0000678_abnormal_parathyroid_gland | 0.65529236 |
| 130 | MP0000249_abnormal_blood_vessel | 0.65418516 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.63995027 |
| 132 | MP0003828_pulmonary_edema | 0.63787611 |
| 133 | MP0009115_abnormal_fat_cell | 0.63480170 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.62196068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 3.93892420 |
| 2 | Annular pancreas (HP:0001734) | 3.81978055 |
| 3 | Colitis (HP:0002583) | 3.78453931 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.54000412 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41476510 |
| 6 | Inflammation of the large intestine (HP:0002037) | 3.36992029 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.28657953 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.27032440 |
| 9 | Gastrointestinal inflammation (HP:0004386) | 3.21258666 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.10309871 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.10309871 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.10309871 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.02716932 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.02716932 |
| 15 | Dysostosis multiplex (HP:0000943) | 2.99477526 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96708109 |
| 17 | Recurrent viral infections (HP:0004429) | 2.92215821 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 2.84161588 |
| 19 | Urethral obstruction (HP:0000796) | 2.71532580 |
| 20 | T lymphocytopenia (HP:0005403) | 2.69300862 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.65509743 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.63121089 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.60391911 |
| 24 | Lymphopenia (HP:0001888) | 2.59620267 |
| 25 | Increased IgM level (HP:0003496) | 2.58270355 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55894899 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55894899 |
| 28 | Intestinal fistula (HP:0100819) | 2.54087723 |
| 29 | Slow saccadic eye movements (HP:0000514) | 2.53328226 |
| 30 | IgA deficiency (HP:0002720) | 2.53249300 |
| 31 | Abnormality of T cell number (HP:0011839) | 2.53129500 |
| 32 | Fatigue (HP:0012378) | 2.51815731 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49609636 |
| 34 | Broad face (HP:0000283) | 2.49280502 |
| 35 | Chronic otitis media (HP:0000389) | 2.48233511 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.44987122 |
| 37 | Recurrent skin infections (HP:0001581) | 2.40572149 |
| 38 | Orchitis (HP:0100796) | 2.39787479 |
| 39 | Poikiloderma (HP:0001029) | 2.38966422 |
| 40 | Febrile seizures (HP:0002373) | 2.37891530 |
| 41 | Basal cell carcinoma (HP:0002671) | 2.36603614 |
| 42 | Viral hepatitis (HP:0006562) | 2.36042836 |
| 43 | Gingivitis (HP:0000230) | 2.35573750 |
| 44 | Focal motor seizures (HP:0011153) | 2.34238323 |
| 45 | Abnormality of T cells (HP:0002843) | 2.33294560 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.33062251 |
| 47 | Male infertility (HP:0003251) | 2.32228052 |
| 48 | Dysmetric saccades (HP:0000641) | 2.31134301 |
| 49 | Granulocytopenia (HP:0001913) | 2.30704937 |
| 50 | Polygenic inheritance (HP:0010982) | 2.24673874 |
| 51 | Chest pain (HP:0100749) | 2.22192584 |
| 52 | Nasal polyposis (HP:0100582) | 2.21404685 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.17793213 |
| 54 | Ocular albinism (HP:0001107) | 2.16931921 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.15469736 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.14532572 |
| 57 | Epistaxis (HP:0000421) | 2.13355267 |
| 58 | IgM deficiency (HP:0002850) | 2.13119614 |
| 59 | Acute lymphatic leukemia (HP:0006721) | 2.13056889 |
| 60 | Cellulitis (HP:0100658) | 2.12313937 |
| 61 | Restrictive lung disease (HP:0002091) | 2.11339443 |
| 62 | Urticaria (HP:0001025) | 2.10332935 |
| 63 | Volvulus (HP:0002580) | 2.08848175 |
| 64 | Osteomyelitis (HP:0002754) | 2.08835710 |
| 65 | Albinism (HP:0001022) | 2.08826238 |
| 66 | Macroorchidism (HP:0000053) | 2.08646134 |
| 67 | Papilledema (HP:0001085) | 2.08486613 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.07422014 |
| 69 | Facial hemangioma (HP:0000329) | 2.06344828 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.05785246 |
| 71 | Ulnar bowing (HP:0003031) | 2.05683182 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.05639282 |
| 73 | Hematochezia (HP:0002573) | 2.05350818 |
| 74 | Atonic seizures (HP:0010819) | 2.05262004 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.04822733 |
| 76 | Syringomyelia (HP:0003396) | 2.04652439 |
| 77 | Spinal cord lesions (HP:0100561) | 2.04652439 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04398328 |
| 79 | Increased CSF protein (HP:0002922) | 2.04316516 |
| 80 | Pulmonary embolism (HP:0002204) | 2.04081878 |
| 81 | Focal seizures (HP:0007359) | 2.02492350 |
| 82 | Visual hallucinations (HP:0002367) | 2.01955493 |
| 83 | Myokymia (HP:0002411) | 2.00822896 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.00076784 |
| 85 | Optic neuritis (HP:0100653) | 2.00076784 |
| 86 | Arterial thrombosis (HP:0004420) | 2.00035694 |
| 87 | Pulmonary infiltrates (HP:0002113) | 1.98535072 |
| 88 | Impaired smooth pursuit (HP:0007772) | 1.98488771 |
| 89 | Polycythemia (HP:0001901) | 1.97905799 |
| 90 | Hemiplegia (HP:0002301) | 1.97751305 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 1.97546065 |
| 92 | Sepsis (HP:0100806) | 1.97470543 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.96931403 |
| 94 | Obstructive lung disease (HP:0006536) | 1.96880905 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96880905 |
| 96 | Encephalitis (HP:0002383) | 1.96668497 |
| 97 | Progressive hearing impairment (HP:0001730) | 1.96118023 |
| 98 | Gingival bleeding (HP:0000225) | 1.95840417 |
| 99 | Mediastinal lymphadenopathy (HP:0100721) | 1.95763748 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 1.95338380 |
| 101 | Meningitis (HP:0001287) | 1.94483251 |
| 102 | Postural instability (HP:0002172) | 1.93066608 |
| 103 | Persistence of primary teeth (HP:0006335) | 1.91623819 |
| 104 | Hypergammaglobulinemia (HP:0010702) | 1.91299881 |
| 105 | Coarse hair (HP:0002208) | 1.91256396 |
| 106 | Micronodular cirrhosis (HP:0001413) | 1.90691716 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 1.90336246 |
| 108 | Obstructive sleep apnea (HP:0002870) | 1.90254515 |
| 109 | Hemoptysis (HP:0002105) | 1.85632970 |
| 110 | Prolonged bleeding time (HP:0003010) | 1.85230675 |
| 111 | Autoimmune hemolytic anemia (HP:0001890) | 1.85152067 |
| 112 | Glucose intolerance (HP:0000833) | 1.85068001 |
| 113 | Anorexia (HP:0002039) | 1.84946077 |
| 114 | Heterotopia (HP:0002282) | 1.84805495 |
| 115 | Hypercortisolism (HP:0001578) | 1.84027871 |
| 116 | Short chin (HP:0000331) | 1.83144627 |
| 117 | Increased IgE level (HP:0003212) | 1.82550400 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 1.82413469 |
| 119 | Malnutrition (HP:0004395) | 1.82062532 |
| 120 | Emphysema (HP:0002097) | 1.79752193 |
| 121 | Skin ulcer (HP:0200042) | 1.78672393 |
| 122 | Iris hypopigmentation (HP:0007730) | 1.78607091 |
| 123 | Gastrointestinal dysmotility (HP:0002579) | 1.78242019 |
| 124 | Myositis (HP:0100614) | 1.76533327 |
| 125 | Clumsiness (HP:0002312) | 1.75802625 |
| 126 | Verrucae (HP:0200043) | 1.75420578 |
| 127 | Papilloma (HP:0012740) | 1.75420578 |
| 128 | Increased connective tissue (HP:0009025) | 1.75324799 |
| 129 | Hyperacusis (HP:0010780) | 1.74640319 |
| 130 | Rib fusion (HP:0000902) | 1.74310714 |
| 131 | Recurrent sinusitis (HP:0011108) | 1.73308263 |
| 132 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.72120232 |
| 133 | Myocardial infarction (HP:0001658) | 1.72035579 |
| 134 | IgG deficiency (HP:0004315) | 1.71464927 |
| 135 | Stomatitis (HP:0010280) | 1.70167490 |
| 136 | Striae distensae (HP:0001065) | 1.67371584 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.67169491 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.67129012 |
| 139 | Esophageal varix (HP:0002040) | 1.67000475 |
| 140 | Progressive sensorineural hearing impairment (HP:0000408) | 1.66760237 |
| 141 | Cheilitis (HP:0100825) | 1.66511909 |
| 142 | Turricephaly (HP:0000262) | 1.66196835 |
| 143 | Abnormality of oral frenula (HP:0000190) | 1.64942424 |
| 144 | Abnormality of the thoracic spine (HP:0100711) | 1.64818688 |
| 145 | Teleangiectasia of the skin (HP:0100585) | 1.64067787 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.63932527 |
| 147 | Chronic diarrhea (HP:0002028) | 1.63474608 |
| 148 | Abnormality of male internal genitalia (HP:0000022) | 1.63453774 |
| 149 | Frequent falls (HP:0002359) | 1.63388885 |
| 150 | Lymphoma (HP:0002665) | 1.63097179 |
| 151 | Arterial tortuosity (HP:0005116) | 1.63038894 |
| 152 | Abnormality of the peritoneum (HP:0002585) | 1.62695280 |
| 153 | Growth hormone excess (HP:0000845) | 1.62267233 |
| 154 | Leukocytosis (HP:0001974) | 1.61733991 |
| 155 | Vasculitis (HP:0002633) | 1.61463799 |
| 156 | Abnormality of binocular vision (HP:0011514) | 1.60575701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.54975121 |
| 2 | ERN1 | 2.95872590 |
| 3 | SMG1 | 2.68342791 |
| 4 | MAPK15 | 2.60330192 |
| 5 | MAP3K6 | 2.54531856 |
| 6 | ICK | 2.31681181 |
| 7 | MAP2K3 | 2.10514976 |
| 8 | SIK1 | 2.09823070 |
| 9 | RIPK4 | 2.06458188 |
| 10 | TYRO3 | 2.00745097 |
| 11 | PRKD2 | 2.00722511 |
| 12 | SIK2 | 1.98078114 |
| 13 | MAP3K9 | 1.93083680 |
| 14 | MAP3K13 | 1.92200074 |
| 15 | EEF2K | 1.90557477 |
| 16 | FGR | 1.79769119 |
| 17 | CDK12 | 1.71968722 |
| 18 | TNK2 | 1.69632022 |
| 19 | CSK | 1.69182188 |
| 20 | MAP3K3 | 1.65788547 |
| 21 | JAK3 | 1.60480067 |
| 22 | DAPK1 | 1.58583076 |
| 23 | TAOK1 | 1.56991837 |
| 24 | TRIB3 | 1.56471197 |
| 25 | TXK | 1.54602018 |
| 26 | MAP3K11 | 1.54117876 |
| 27 | BMX | 1.51921810 |
| 28 | FES | 1.44122344 |
| 29 | JAK1 | 1.42153895 |
| 30 | DDR2 | 1.39457717 |
| 31 | PRKCH | 1.37738405 |
| 32 | PDGFRA | 1.37252644 |
| 33 | EPHA4 | 1.31912051 |
| 34 | TGFBR2 | 1.28588112 |
| 35 | HIPK2 | 1.28516449 |
| 36 | NTRK3 | 1.26063349 |
| 37 | TYK2 | 1.25464131 |
| 38 | MATK | 1.20347589 |
| 39 | ALK | 1.19370264 |
| 40 | PINK1 | 1.18772662 |
| 41 | EPHB1 | 1.18140778 |
| 42 | TTN | 1.15088671 |
| 43 | RIPK1 | 1.14429953 |
| 44 | PRKD3 | 1.10559126 |
| 45 | MARK2 | 1.08973962 |
| 46 | CAMK1D | 1.08756569 |
| 47 | HCK | 1.07985981 |
| 48 | TAOK3 | 1.07695759 |
| 49 | STK38 | 1.06834453 |
| 50 | MAP3K10 | 1.06805299 |
| 51 | CAMK1G | 1.06361640 |
| 52 | ZAP70 | 1.04212389 |
| 53 | MAP3K14 | 1.01487328 |
| 54 | UHMK1 | 0.99927779 |
| 55 | CDC42BPA | 0.99595899 |
| 56 | ITK | 0.98960034 |
| 57 | DMPK | 0.97867873 |
| 58 | PKN2 | 0.97036124 |
| 59 | SYK | 0.96961167 |
| 60 | MAP3K7 | 0.96833442 |
| 61 | CSF1R | 0.96576149 |
| 62 | KSR2 | 0.94102149 |
| 63 | STK10 | 0.93212767 |
| 64 | PDGFRB | 0.93207296 |
| 65 | JAK2 | 0.92713566 |
| 66 | LCK | 0.92529346 |
| 67 | CAMKK1 | 0.91100347 |
| 68 | PRPF4B | 0.90778772 |
| 69 | PTK6 | 0.88961623 |
| 70 | PAK6 | 0.88785647 |
| 71 | SGK3 | 0.87363850 |
| 72 | CDK4 | 0.86370053 |
| 73 | DAPK2 | 0.86103661 |
| 74 | MAPK12 | 0.85103501 |
| 75 | TAOK2 | 0.83924870 |
| 76 | RPS6KB2 | 0.82464556 |
| 77 | PDPK1 | 0.82122788 |
| 78 | MELK | 0.81878814 |
| 79 | FGFR3 | 0.80779515 |
| 80 | IKBKE | 0.80645781 |
| 81 | NTRK2 | 0.80362299 |
| 82 | RAF1 | 0.79622879 |
| 83 | GRK6 | 0.78826870 |
| 84 | CDK6 | 0.77252662 |
| 85 | LMTK2 | 0.73223885 |
| 86 | MAP2K2 | 0.72891004 |
| 87 | PIM1 | 0.72431942 |
| 88 | MAPK7 | 0.71976143 |
| 89 | MTOR | 0.71627670 |
| 90 | PDK1 | 0.71434116 |
| 91 | TRPM7 | 0.68752555 |
| 92 | IKBKB | 0.66944822 |
| 93 | FGFR4 | 0.66728551 |
| 94 | CHUK | 0.64958095 |
| 95 | MAP3K1 | 0.64231179 |
| 96 | RET | 0.63147968 |
| 97 | PASK | 0.63079032 |
| 98 | MST1R | 0.61828941 |
| 99 | IRAK2 | 0.61383895 |
| 100 | STK11 | 0.60550312 |
| 101 | LYN | 0.60348644 |
| 102 | CDK9 | 0.60018142 |
| 103 | SGK1 | 0.59491168 |
| 104 | KIT | 0.58372547 |
| 105 | BTK | 0.58232786 |
| 106 | IRAK3 | 0.58012295 |
| 107 | MAPK11 | 0.57462781 |
| 108 | RPS6KL1 | 0.57174288 |
| 109 | RPS6KC1 | 0.57174288 |
| 110 | YES1 | 0.57168052 |
| 111 | MARK3 | 0.56765739 |
| 112 | RPS6KA6 | 0.56279363 |
| 113 | EPHA2 | 0.53223770 |
| 114 | LRRK2 | 0.52358654 |
| 115 | MAP3K2 | 0.51294994 |
| 116 | NEK6 | 0.51057934 |
| 117 | CAMK4 | 0.50145313 |
| 118 | SIK3 | 0.47741558 |
| 119 | EGFR | 0.47331654 |
| 120 | MAPK10 | 0.45922640 |
| 121 | MAP3K4 | 0.45893678 |
| 122 | SGK2 | 0.45611599 |
| 123 | PAK4 | 0.45209496 |
| 124 | NME2 | 0.44895256 |
| 125 | TBK1 | 0.44526979 |
| 126 | BLK | 0.44209693 |
| 127 | NEK9 | 0.43484017 |
| 128 | CDK5 | 0.43429118 |
| 129 | RPS6KA2 | 0.43337136 |
| 130 | IRAK4 | 0.43263812 |
| 131 | BMPR2 | 0.42369429 |
| 132 | PRKG2 | 0.41588160 |
| 133 | MAP3K8 | 0.41355000 |
| 134 | TEC | 0.40281239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15679848 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96482601 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90662356 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 1.89654841 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86909740 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.62061804 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58643565 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54434142 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53953121 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48888765 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48607671 |
| 12 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.43396096 |
| 13 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.42342035 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38688821 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34823387 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34126956 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33768726 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33313511 |
| 19 | Hepatitis C_Homo sapiens_hsa05160 | 1.26432971 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.26122469 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.25222227 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24797923 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24138831 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20613395 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18113138 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16781048 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15831136 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15199481 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15174074 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15006864 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13798524 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12276547 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11891571 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.10128785 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10023571 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.09695681 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.09408678 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08966716 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.06670650 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05954582 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05910704 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05288821 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05206925 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03083547 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03040467 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02693926 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02276752 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02179609 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01832862 |
| 50 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.01685994 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.00429845 |
| 52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00351705 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00244112 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99133761 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99096690 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98029316 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.97949413 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97141424 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96745967 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96183010 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92982474 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.92726359 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92149374 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91605273 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91187832 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.90629690 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89631552 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.89494228 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89369700 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.89097530 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88918330 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88488437 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88180204 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.87917754 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87772721 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.87143634 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86406621 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86020780 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85635465 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85380471 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84664672 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.84039359 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83969033 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83964204 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83704036 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83672798 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83644650 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81651119 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81391936 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.81245966 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.81100622 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.80303953 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78949457 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78333251 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77606390 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77411401 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77324182 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.76810007 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.76346319 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75378548 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74904614 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74316159 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.73565836 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73516697 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72611191 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.72527474 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72415172 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71970419 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71788256 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71451285 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70899176 |
| 112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70607709 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70279136 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69165584 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68354343 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66795928 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66129949 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.65122479 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.64552096 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63328142 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60231850 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59009189 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58988491 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58957605 |
| 125 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58391348 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57974546 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57598411 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57144771 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56922082 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.51910661 |
| 131 | Focal adhesion_Homo sapiens_hsa04510 | 0.50445782 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46896970 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46484805 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.45712589 |

